Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
UCSF Teams Up With Zambon’s Zcube Unit
by Lisa M. Jarvis
March 7, 2011
| A version of this story appeared in
Volume 89, Issue 10
University of California, San Francisco, and Zcube, the research venture arm of Italian drug firm Zambon, will work together on oral drug delivery technology. Through the two-year pact, UCSF bioengineering and therapeutic sciences professor Tejal Desai secures funding to support his research on delivering drugs to the small intestine and colon. The Desai laboratory has developed tiny sticky devices, each with a drug-filled reservoir, that can be packed into a pill. When released in the intestine, the “micropads” stick to the gastrointestinal tract and deliver medicine directly to the intestinal lining.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X